Stanford, CA, United States of America

Xiaoyu Zang

This inventor holds 2 USPTO granted patents. Top assignee: Leland Stanford Junior University. Active years: 2022-2025.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Inventor Xiaoyu Zang

Introduction

Xiaoyu Zang is an accomplished inventor based in Stanford, California. He has made significant contributions to the field of antimicrobial agents and prodrug derivatives, holding two patents that showcase his innovative approach to addressing complex medical challenges.

Latest Patents

Zang's latest patents include a composition and method for new antimicrobial agents with a secondary mode of action. This invention involves antibiotic agents conjugated to a guanidinium-rich molecular transporter, which demonstrates increased efficacy against difficult-to-treat bacterial infections, including biofilms and multi-drug resistant bacteria. His second patent focuses on prodrug derivatives of protein kinase C modulators. These prodrugs exhibit low toxicity and improved stability, making them valuable for academic research and potential therapeutic applications.

Career Highlights

Xiaoyu Zang is affiliated with Leland Stanford Junior University, where he continues to advance his research and innovation in the field of pharmaceuticals. His work has garnered attention for its potential impact on treating bacterial infections and enhancing drug efficacy.

Collaborations

Zang collaborates with notable colleagues, including Paul A. Wender and Melanie Huttner, who contribute to his research endeavors and help drive forward the development of his innovative solutions.

Conclusion

Xiaoyu Zang's contributions to the field of antimicrobial agents and prodrug derivatives highlight his role as a leading inventor in medical research. His patents reflect a commitment to addressing significant health challenges through innovative solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…